2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-N,N,1-trimethylbenzimidazole-5-carboxamide
C22H25ClFN5O3S — CID 50822527
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-N,N,1-trimethylbenzimidazole-5-carboxamide
2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-N,N,1-trimethylbenzimidazole-5-carboxamide (PubChem CID 50822527) has the molecular formula C22H25ClFN5O3S and a molecular weight of 493.99 g/mol. Its IUPAC name is 2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-N,N,1-trimethylbenzimidazole-5-carboxamide.
Molecular Properties
| Compound Name | 2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-N,N,1-trimethylbenzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 50822527 |
| Molecular Formula | C22H25ClFN5O3S |
| Molecular Weight | 493.99 g/mol |
| Exact Mass | 493.14 |
| IUPAC Name | 2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-N,N,1-trimethylbenzimidazole-5-carboxamide |
| SMILES | CN(C)C(=O)c1ccc2c(c1)nc(CN1CCN(S(=O)(=O)c3ccc(F)c(Cl)c3)CC1)n2C |
| InChI | InChI=1S/C22H25ClFN5O3S/c1-26(2)22(30)15-4-7-20-19(12-15)25-21(27(20)3)14-28-8-10-29(11-9-28)33(31,32)16-5-6-18(24)17(23)13-16/h4-7,12-13H,8-11,14H2,1-3H3 |
| InChIKey | SIXMCZXERQINDR-UHFFFAOYSA-N |
| XLogP | 2.57 |
| TPSA | 78.75 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 493.99 |
| LogP ≤ 5 | 2.57 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 50822527 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.